ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,973.10
0.74%
US Tech 100
20,544.40
1.59%
Dow Jones
43,729.34
0.00%
Brent Oil
75.155
-0.40%
Bitcoin
76,089.44
0.25%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Taysha Gene Therapies Inc (TSHA)

  7. Taysha Gene Therapies Inc (TSHA) News

Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

NASDAQ
1.42
0.05
(3.65%)
Closed November 08 4:00PM
Delayed by 15 minutes
1.47
0.05
(3.52%)
After Hours: 7:47PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

TSHA News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
January 10 2024
TSHA (3.65%)

Form 8-K - Current report
Edgar (US Regulatory)
December 20 2023
TSHA (3.65%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
December 20 2023
TSHA (3.65%)

TSHA Discussion

View Posts
Monksdream Monksdream 3 weeks ago
TSHA under $3
👍️0
Monksdream Monksdream 3 months ago
TSHA under $3
👍️0
TechandBio TechandBio 4 months ago
Started buying shares last year at .77 Riding the houses money now and sold three quarters of my shares at $4.00 range when I saw the double top formation come into play I can see this going to $8.00-$10.00 only on a buyout in the next year. Risky with only a handful of patients dosed and the competition for Rhett but a cunning bet with the management at TSHA. now.
CEO and CMO are best in class. Not a core position but glad I'm in with a few. I hope they have a remedy for these poor kids with Rhett.

$TSHA
👍️0
nsomniyak nsomniyak 4 months ago
If these are senior people in prominent management or technical roles it is pretty standard for them to be granted options as part of their compensation package. They vest over 4 years, so it is not an outright giveaway.

Additionally, since these are NEW employees, by definition they have not manipulated the stock down to get a lower option strike price.

I am fine with this very normal comp package.
👍️ 1
ErnieBilco ErnieBilco 4 months ago
I'm sorry but granting options to NEW employees is absurd - they shouldn't be entitled to stock options UNTIL their one year on the job.

No wonder why this has trouble making gains for shareholders whom the employees actually work for.
👍️0
LegendaryNomad22 LegendaryNomad22 5 months ago
Weird. Both TSHA and NGNE have gene therapy candidates for Rett and both of them tanked today, despite sharing strong interim results. There's an International Rett Syndrome Foundation meeting today and tomorrow, so I wonder if something happened there to take the wind out of the gene therapy treatment class. Anyone have any knowledge here?
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
Diluted on news
👍️0
Pip611 Pip611 5 months ago
Ouch - what happen?
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA...GAPPING
👍️0
Tiger Money Tiger Money 5 months ago
Yes, no sorry, didn’t mean to imply that. I was asking if you have other bio names you have on your radar (obviously know about this and Huma). Thanks
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
chart has nothing to do with what sector!!
👍️0
Tiger Money Tiger Money 5 months ago
You have the bios nailed down! Any I should put on my radar? As always, thank you as I sincerely appreciate your help and knowledge. Thanks!
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA BREAK OUT
👍️0
Monksdream Monksdream 5 months ago
TSHA new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA...HERES 4 DOLLA
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA...READY FOR 4
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA...BIO BEAST BREAKING HEWRE CHAINS
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA HERE WE GO ON THE BREAK OUT!!
👍️0
glenn1919 glenn1919 5 months ago
TSHA......................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA HERE COMES THE BREAK
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
TSHA...NEXT BIO READY TO BEAST!
👍️0
FooBarAndGrill FooBarAndGrill 5 months ago
Taysha may have the real ONE-SHOT genetic cure. It may REALLY work.
Good luck getting any health insurance plan to list this $Million dollar shot in their drug formulary.
👍️0
Monksdream Monksdream 5 months ago
TSHA under $5
👍️0
glenn1919 glenn1919 8 months ago
TSHA..............................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
TSHA..READY TO PUSH TO 4.00
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
TSHA...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
TSHA...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
TSHA..here we go
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
TSHA...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
TSHA NEXT BIO BEAST TO RUN TO 3.61 WATCH THE MAGIC
👍️0
FooBarAndGrill FooBarAndGrill 10 months ago
“Dosing the first pediatric patient with Rett syndrome marks an important step forward in our efforts to broaden the clinical evaluation of TSHA-102 to younger patients with earlier stages of Rett syndrome. We are pleased with our progress on expanding the study of TSHA-102 across a broad population of ages and stages of Rett syndrome to bring a potentially transformative treatment option to all patients and families suffering from this devastating disease,” said Sukumar Nagendran, M.D., President, and Head of R&D of Taysha. “The pediatric trial will build on our ongoing REVEAL adolescent and adult trial, where early data demonstrated improvements across multiple clinical domains in adult patients with the most advanced stage of disease. We also plan to expand our U.S. pediatric trial into the U.K. following the recent acceptance of our CTA by the MHRA.”
👍️0
FooBarAndGrill FooBarAndGrill 11 months ago
Estimated Enrollment : 18 participants
(was 12).
https://classic.clinicaltrials.gov/ct2/show/NCT05606614
👍️0
FooBarAndGrill FooBarAndGrill 11 months ago
“Following review of the initial clinical data from the first two adult patients treated with TSHA-102 and Chemistry, Manufacturing, and Controls (CMC) data, Health Canada has authorized our protocol amendment to include adolescent patients aged 12 years and older in the ongoing REVEAL Phase 1/2 adult trial,”
https://ih.advfn.com/stock-market/NASDAQ/taysha-gene-therapies-TSHA/stock-news/92678004/taysha-gene-therapies-announces-expanded-eligibili
👍️0
FooBarAndGrill FooBarAndGrill 12 months ago
The P1 TSHA-102 REVEAL Adult Study has been on a slow boat.
Hopefully, the Clinical Updates PR will give the push to finally complete enrollment of the 12 adult female Rett patients needed for the trial.
I'm guessing reluctance to enroll has been based on the one-time injection into the intrathecal space (directly into the Cerebral Spinal Fluid).
It's definitely worth the risk, IMO. Good Luck to All.
👍️0
bikaver bikaver 1 year ago
TSHA.....Definitely headed in the right direction now. A couple more days of downward momo would be great.
👍️0
make it happen make it happen 1 year ago
Cannacord Genuity and Truist Securities both lowered there price targets, never a good thing...
👍️0
make it happen make it happen 1 year ago
Think it's about there. I believe we flush under $3.00 and don't come back to the this price per share PPS till R/S. A ways away but see it happening. JMHO
👍️0
bikaver bikaver 1 year ago
TSHA.....kicking my butt.....next week is make or break!
👍️0
Triple nickle Triple nickle 1 year ago
Good call my .90 are looking ripe
👍️0
bikaver bikaver 1 year ago
Added 3.28 today.
👍️0
bikaver bikaver 1 year ago
TSHA.....Today, all day, was a bull trap. Tomorrow could be Free Falling Friday.
👍️0
bikaver bikaver 1 year ago
TSHA.....The buyers at 2.85-2.91 proves the phrase "There's a sucker born every minute." to be true.
👍️0
richme richme 1 year ago
Looks like the rocket exploded! Was tempted to buy; glad I did not!

Finally bought 2.19 for 6K shares; too soon; down more now to 2.14.
👍️0
Jess070283 Jess070283 1 year ago
Blast off at open?
👍️0
riha riha 1 year ago
at least i don't feel foolish now.

tomorrow though... i might.
👍️0
alchemytrader alchemytrader 1 year ago
be glad you didnt get any. hit 2.91 a/h.
👍️0
alchemytrader alchemytrader 1 year ago
2.85 RIP
👍️0
Triple nickle Triple nickle 1 year ago
Tif function
👍️0
riha riha 1 year ago
I can't get any shorts... fuck
👍️0
bikaver bikaver 1 year ago
TSHA..... added 2.10 short into this strong close.
👍️0

Your Recent History

NASDAQ
TSHA
Taysha Gene Therapies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved